Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Return on Assets (2020 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Return on Assets for 6 consecutive years, with 0.3% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 85.0% to 0.3% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3% through Dec 2025, up 85.0% year-over-year, with the annual reading at 0.35% for FY2025, 76.0% up from the prior year.
  • Return on Assets hit 0.3% in Q4 2025 for Insight Molecular Diagnostics, up from 1.3% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.04% in Q4 2023 to a low of 1.3% in Q3 2025.
  • Historically, Return on Assets has averaged 0.5% across 5 years, with a median of 0.39% in 2021.
  • Biggest five-year swings in Return on Assets: tumbled -112bps in 2024 and later surged 85bps in 2025.
  • Year by year, Return on Assets stood at 0.39% in 2021, then decreased by -8bps to 0.42% in 2022, then soared by 91bps to 0.04% in 2023, then tumbled by -2993bps to 1.16% in 2024, then skyrocketed by 74bps to 0.3% in 2025.
  • Business Quant data shows Return on Assets for IMDX at 0.3% in Q4 2025, 1.3% in Q3 2025, and 1.15% in Q2 2025.